{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:49:38Z","timestamp":1788569378011,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.nucmedbio.2018.01.004","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T10:28:43Z","timestamp":1517394523000},"page":"37-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["[18F]RPS-544: A PET tracer for imaging the chemokine receptor CXCR4"],"prefix":"10.1016","volume":"60","author":[{"given":"Alejandro","family":"Amor-Coarasa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashikanth","family":"Ponnala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6708-5358","authenticated-orcid":false,"given":"Yogindra","family":"Vedvyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Nikolopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Clarence","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moonsoo M.","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"David Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Babich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0005","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.4049\/jimmunol.159.9.4322","article-title":"Cloning and analysis of the promoter region of CXCR4, a coreceptor for HIV-1 entry","volume":"159","author":"Moriuchi","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0010","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.4049\/jimmunol.168.8.4121","article-title":"CXCR4 function requires membrane cholesterol: implications for HIV infection","volume":"168","author":"Nguyen","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0015","first-page":"809","article-title":"The critical role of SDF-1\/CXCR4 axis in cancer and cancer stem cells metastasis","volume":"31","author":"Gelmini","year":"2008","journal-title":"J Endocrinol"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0020","first-page":"1333","article-title":"CXCR4 nuclear localization follows binding of its ligand SDF-1 and occurs in metastatic but not primary renal cell carcinoma","volume":"22","author":"Wang","year":"2009","journal-title":"Oncol Rep"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0025","first-page":"525","article-title":"Expression and potential role of chemokine receptor CXCR4 in human bladder carcinoma cell lines with different metastatic ability","volume":"4","author":"Wang","year":"2011","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0030","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.exphem.2006.03.013","article-title":"Negative regulation of MHC class II gene expression by CXCR4","volume":"34","author":"Sheridan","year":"2006","journal-title":"Exp Hematol"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0035","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/sj.bjc.6605020","article-title":"High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma","volume":"100","author":"Marechal","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0040","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1440-1827.2010.02548.x","article-title":"CXCR4 and cancer","volume":"60","author":"Furusato","year":"2010","journal-title":"Pathol Int"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/B978-0-12-411638-2.00002-1","article-title":"The intricate role of CXCR4 in cancer","volume":"124","author":"Chatterjee","year":"2014","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0055","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/cmdc.201100320","article-title":"PET imaging of CXCR4 receptors in cancer by a new optimized ligand","volume":"6","author":"Demmer","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7150\/thno.16576","article-title":"[68Ga]Pentixafor-PET\/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma \u2013comparison to [18F]FDG and laboratory values","volume":"7","author":"Lapa","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0065","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.2353\/ajpath.2010.090607","article-title":"COX-2 and prostaglandin EP3\/EP4 signaling regulate the tumor stromal proangiogenic microenvironment via CXCL12-CXCR4 chemokine systems","volume":"176","author":"Katoh","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0070","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s11912-012-0230-3","article-title":"Renal cell carcinoma deep sequencing: recent developments","volume":"14","author":"Farber","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7150\/thno.5760","article-title":"CXCR4 chemokine receptor overview: biology, pathology and applications in imaging and therapy","volume":"3","author":"Jacobson","year":"2013","journal-title":"Theranostics"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000351952","article-title":"CXCR4 expression in bladder transitional cell carcinoma and its relationship with Clinicopathological features","volume":"92","author":"Li","year":"2014","journal-title":"Urol Int"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0085","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0090","doi-asserted-by":"crossref","first-page":"77S","DOI":"10.2967\/jnumed.116.186874","article-title":"CXCR4 ligands: the next big hit?","volume":"58","author":"Walenkamp","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0095","doi-asserted-by":"crossref","first-page":"618","DOI":"10.7150\/thno.11251","article-title":"Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging","volume":"5","author":"Wester","year":"2015","journal-title":"Theranostics"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0100","doi-asserted-by":"crossref","first-page":"428","DOI":"10.7150\/thno.13986","article-title":"68Ga-Pentixafor-PET\/CT for imaging of chemokine receptor 4 expression in glioblastoma","volume":"6","author":"Lapa","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0105","doi-asserted-by":"crossref","first-page":"9288","DOI":"10.18632\/oncotarget.7063","article-title":"[68Ga]Pentixafor-PET\/CT for imaging of chemokine receptor 4 expression in small cell lung cancer - initial experience","volume":"7","author":"Lapa","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0110","doi-asserted-by":"crossref","first-page":"477","DOI":"10.15252\/emmm.201404698","article-title":"In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma","volume":"7","author":"Philipp-Abbrederis","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0115","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.7150\/thno.18754","article-title":"Imaging of chemokine receptor 4 expression in neuroendocrine tumors - a triple tracer comparative approach","volume":"7","author":"Werner","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0120","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3324\/haematol.2016.142976","article-title":"Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia","volume":"101","author":"Herhaus","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0125","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13550-017-0294-z","article-title":"Response assessment with the CXCR4-directed positron emission tomography tracer [68Ga]Pentixafor in a patient with extranodal marginal zone lymphoma of the orbital cavities","volume":"7","author":"Herhaus","year":"2017","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0130","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.2967\/jnumed.115.171249","article-title":"Comprehensive quality control of the ITG 68Ge\/68Ga generator and synthesis of 68Ga-DOTATOC and 68Ga-PSMA-HBED-CC for clinical imaging","volume":"57","author":"Amor-Coarasa","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.apradiso.2012.06.034","article-title":"Comparison of Gallium-68 and Fluorine-18 imaging characteristics in positron emission tomography","volume":"76","author":"Sanchez-Crespo","year":"2013","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.18383\/j.tom.2016.00130","article-title":"First 18F-labeled Pentixafor-based imaging agent for PET imaging of CXCR4 expression in vivo","volume":"2","author":"Poschenrieder","year":"2016","journal-title":"Tomography"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0145","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2967\/jnumed.112.113563","article-title":"First experience of 18F-Alfatide in lung caner patients using a new lyophilized kit for rapid Radioluorination","volume":"54","author":"Wan","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0150","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1007\/s00259-011-1847-4","article-title":"One-step radiosynthesis of 18F-AlF-NOTA-RGD2 for tumor angiogenesis PET imaging","volume":"38","author":"Liu","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.nucmedbio.2018.01.004_bb0155","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7150\/thno.5376","article-title":"Small molecule inhibitors of CXCR4","volume":"3","author":"Debnath","year":"2013","journal-title":"Theranostics"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0160","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejmech.2016.02.051","article-title":"Discovery of non-peptide small molecular CXCR4 antagonists as anti-HIV agents: recent advances and future opportunities","volume":"114","author":"Zhang","year":"2016","journal-title":"Eur J Med Chem"},{"issue":"10","key":"10.1016\/j.nucmedbio.2018.01.004_bb0165","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.nucmedbio.2016.05.005","article-title":"Synthesis and evaluation of an 18F-labeled pyrimidine-pyridine amine for targeting CXCR4 receptors in gliomas","volume":"43","author":"Demoin","year":"2016","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0170","doi-asserted-by":"crossref","first-page":"8556","DOI":"10.1021\/jm100786g","article-title":"Dipyrimidine amines: a novel class of chemokine receptor type 4 antagonists with high specificity","volume":"53","author":"Zhu","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0175","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.bcp.2005.05.035","article-title":"AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor","volume":"70","author":"Hatse","year":"2005","journal-title":"Biochem Pharmacol"},{"issue":"19","key":"10.1016\/j.nucmedbio.2018.01.004_bb0180","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.90064","article-title":"Longitudinal PET imaging demonstrates biphasic CAR T cell responses in survivors","volume":"1","author":"Vedvyas","year":"2016","journal-title":"JCI Insight"},{"issue":"21","key":"10.1016\/j.nucmedbio.2018.01.004_bb0185","doi-asserted-by":"crossref","first-page":"9891","DOI":"10.1158\/0008-5472.CAN-05-1293","article-title":"Up-regulation of CXCR4 expression in PC-3 cells by stromal derived factor-1A (CXCL12) increases endothelial adhesion and Transendothelial migration: role of MEK\/ERK signaling pathway\u2013dependent NF-KB activation","volume":"65","author":"Kukreja","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2018.01.004_bb0190","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.bcp.2006.05.010","article-title":"Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4","volume":"72","author":"Fricker","year":"2006","journal-title":"Biochem Pharmacol"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805117303529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805117303529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T19:37:43Z","timestamp":1693510663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805117303529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":38,"alternative-id":["S0969805117303529"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2018.01.004","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[18F]RPS-544: A PET tracer for imaging the chemokine receptor CXCR4","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2018.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}